We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Ion-Selective Electrode Methods Compared for Electrolytes

By LabMedica International staff writers
Posted on 02 Jul 2019
Print article
Image: The RAPIDPoint 500 Blood Gas System delivers fast, accurate and comprehensive test results for whole blood samples in approximately 60 seconds (Photo courtesy of Siemens Healthineers).
Image: The RAPIDPoint 500 Blood Gas System delivers fast, accurate and comprehensive test results for whole blood samples in approximately 60 seconds (Photo courtesy of Siemens Healthineers).
Electrolytes are among the most commonly requested clinical laboratory tests. There are two methods for measuring electrolytes in plasma, both using the principle of an ion-selective electrode (ISE).

The first method, used in point-of-care blood gas analyzers, is direct potentiometry, which measures electrolyte activity in plasma without dilution. The second method, used in routine chemistry analyzers in central laboratories, is indirect ISE, which involves a pre-analytical serum or plasma dilution step.

Clinical biochemists at the Leiden University Medical Center (Leiden, The Netherlands) and their colleagues used anonymized laboratory results of patients admitted to the emergency room and intensive care unit, and demonstrated in four steps that this lack of interchangeability of sodium and chloride results can be attributed to differences in measurement principle, but also to analytical standardization issues of the blood gas analyzers.

The team extracted blood gas results performed on a RAPIDPoint 500 and routine chemistry performed on a Modular P800 sodium and chloride results for patients admitted to the emergency room of their hospital between June 1, 2014, and May 17, 2016.

The team investigated the effects of the introduction of the instrument factors in the blood gas analysers, by extracting blood gas and routine chemistry sodium and chloride results (with a maximum time of 1 hour between sample analysis) again for patients admitted to the emergency room of our hospital. This approach eliminated the systematic differences between blood gas and serum sodium for 92 emergency department patients, and reduced the mean difference in chloride to 1 mmol/L for 25 patients. The mean difference in sodium results between blood gas and serum for intensive care patients decreased from 4 mmol/L to 2 mmol/L.

The authors concluded that standardization of sodium and chloride across methods and matrices is not a simple task and emphasizes the need for a close collaboration between laboratory specialists and clinicians regarding education on pitfalls in laboratory medicine. The study was published on June 13, 2019, in the journal Practical Laboratory Medicine.

Related Links:
Leiden University Medical Center

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Nutating Mixer
Enduro MiniMix
New
PSA Test
Humasis PSA Card

Print article

Channels

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.